Skip to main content
. 2020 Sep 3;18:99. doi: 10.1186/s12961-020-00586-w

Table 3.

Previous exposure to and importance of future development in health economics topics among survey respondents (n = 73)

Health economics topic Previous exposure - # respondents (%) Importance of future development
I am an expert on this topic I completed a face-to-face course on this topic I completed an online course on this topic I have worked on this topic No exposure to this topic Average rank (SD, IQR) # respondents ranking the topic in top 3 (%)
Measuring the economic burden of disease 9 (12.3%) 14 (19.2%) 4 (5.5%) 20 (27.4%) 33 (45.2%) 4.56 (2.67, 3-6) 32 (43.8%)
Economic evaluation 10 (13.7%) 14 (19.2%) 5 (6.8%) 28 (38.4%) 28 (38.4%) 4.68 (3.06, 2-7) 35 (47.9%)
Measuring health equity 5 (6.8%) 14 (19.2%) 1 (1.4%) 12 (16.4%) 48 (65.8%) 4.96 (2.76, 3-7) 25 (34.2%)
Measuring health utilities and HRQoL 10 (13.7%) 14 (19.2%) 4 (5.5%) 30 (41.1%) 26 (35.6%) 5.18 (2.99, 3-8) 25 (34.2%)
Measuring the efficiency of health systems or providers 6 (8.2%) 11 (15.1%) 3 (4.1%) 10 (13.7%) 47 (64.4%) 5.27 (2.83, 3-7) 24 (32.9%)
Measuring healthcare costs 8 (11.0%) 14 (19.2%) 2 (2.7%) 23 (31.5%) 35 (47.9%) 5.33 (2.53, 4-7) 18 (24.7%)
Formal policy analysis 3 (4.1%) 10 (13.7%) 1 (1.4%) 16 (21.9%) 44 (60.3%) 5.96 (2.72, 4-8) 16 (21.9%)
Measuring preferences of health workers or patients 8 (11.0%) 10 (13.7%) 2 (2.7%) 16 (21.9%) 41 (56.2%) 6.05 (2.70, 4-8) 17 (23.3%)
Political economy analysis 3 (4.1%) 9 (12.3%) 2 (2.7%) 15 (20.5%) 48 (65.8%) 6.71 (3.4, 4-10) 17 (23.3%)
Quasi-experimental methods 8 (11.0%) 12 (16.4%) 2 (2.7%) 14 (19.2%) 40 (54.8%) 7.15 (3.0, 5-10) 10 (13.7%)
Other - - - - - 10.14 (1.7, 10-11) 0 (0%)

For “Previous exposure” the survey question was “Thinking about the past 5 years (since September 2014), choose the statements that apply to you for each of the following topics. Choose all statements that apply. For the purpose of this question, the following are NOT sufficient to be considered a 'course': one-day activities; individual study without an instructor; attending one-off lectures, conference presentations, seminars, webinars.”; line totals do not add up to 100% because respondents could choose more than one response item under each health economics topic

For “Importance of future development” the survey question was “Which of the following health economics topics do you consider most important for you to develop in the future?

Order (drag and drop) the following options from the most important (1) to the least important (11).” Results exclude three respondents outside the four focal jurisdictions and seven respondents with policy or management roles

Abbreviations: HRQoL health-related quality of life, IQR interquartile range, SD standard deviation